Our results are in agreement with a recent report showing increased ERK1/2 activity in the retina of one-week diabetic rats compared to normal rats and pretreatment of the retina with U0126 attenuating diabetes-induced ERK1/2 activation [28]. The gene discussed is MAPK3; the disease is diabetes mellitus.